Breaking● Reported
Claris Biotherapeutics Releases Positive CSB-001 Clinical Proof-of-Concept Data in Limbal Stem Cell Deficiency at AAO 2026 Annual Meeting
reported
Market reaction
Linked assets at the first close after the story opened, against the close before. Timing, not proof of cause.
Who is covering it
Distinct sources by type; one outlet counts once.
News 1
What the updates added
New fact · 1Nothing new · 1
Story timeline
Sunday 11 Oct 2026
23:00
New fact
Business Insider — Markets
Tuesday 13 Oct 2026
21:31
Nothing new
Business Insider — Markets